Pricing Log in Create free account

Lipocine Inc. (LPCN) vs RVL Pharmaceuticals PLC (RVLP)

Lipocine Inc. and RVL Pharmaceuticals PLC are both Biotechnology companies. Lipocine Inc. and RVL Pharmaceuticals PLC are of similar size ($14.1M and $13.9M). RVL Pharmaceuticals PLC grew revenue faster over the last twelve months: 5.64% against −63.5%. RVL Pharmaceuticals PLC has the higher net margin (−184.9% vs −755.1%) and the lower return on invested capital (−80.5% vs 0.00%). Across the 16 metrics below, Lipocine Inc. leads on 8 and RVL Pharmaceuticals PLC on 8.

Valuation

Metric LPCN RVLP Biotechnology median
P/E n/m n/m 8.50
P/S 7.75 n/m 9.71
P/B 0.56 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.64 n/m 0.64
EV/Sales (5.21) 1.05 9.21
Earnings yield (126.35%) 0.00% (33.15%)
Free cash flow yield (92.84%) 0.00% (25.50%)

Profitability

Metric LPCN RVLP Biotechnology median
Gross margin 100.00% 74.73% 65.16%
Operating margin (800.80%) (191.72%) 0.00%
Net margin (755.11%) (184.91%) 0.00%
Free cash flow margin (713.02%) (128.42%) 0.00%
Return on equity (60.94%) (182.44%) (56.36%)
Return on assets (55.89%) (64.94%) (48.04%)
Return on invested capital 0.00% (80.54%) 0.00%

Growth

Metric LPCN RVLP Biotechnology median
Revenue growth (TTM) (63.48%) 5.64% 6.02%
EPS growth (last fiscal year) (93,988.89%) 39.58% 30.26%
Revenue growth, 5-year CAGR 64.32% (27.35%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LPCN RVLP Biotechnology median
Debt to equity 0.00 3.54 0.00
Current ratio 11.48 0.38 4.72
Net debt to EBITDA 1.42 (0.29) 0.96

Dividend

Metric LPCN RVLP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LPCN RVLP Biotechnology median
Market cap 13.85m 14.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack